Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 42.02%: Here's is How to Trade
Portfolio Pulse from
Wall Street analysts have set an average price target for Castle Biosciences (CSTL) indicating a potential upside of 42%. This is supported by positive trends in earnings estimate revisions, suggesting a possible rally in the stock.
December 16, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Castle Biosciences (CSTL) is projected to have a 42% upside based on analyst price targets. Positive earnings estimate revisions support this potential rally.
Analyst price targets suggest a significant upside for CSTL, and the positive trend in earnings estimate revisions further supports the potential for a stock rally. This combination of factors is likely to positively impact CSTL's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100